CTS Corporation reported fourth‑quarter 2025 revenue of $137.27 million, up 9% year‑over‑year and beating consensus estimates of $135.86 million by $1.41 million. The lift was driven by a 16% increase in diversified end‑market sales, which now account for 57% of total revenue, while transportation sales declined 1% year‑over‑year, contributing to a shift in the revenue mix.
Adjusted diluted earnings per share rose to $0.62, surpassing the consensus of $0.61 by $0.01 (a 1.6% beat). The EPS beat reflects disciplined cost management and a favorable product mix that increased margin contribution from high‑margin aerospace & defense and medical segments. For comparison, Q4 2024 adjusted diluted EPS was $0.50, indicating a 24% year‑over‑year increase.
Margin expansion continued, with adjusted gross margin rising to 39.1% from 38.5% year‑over‑year and adjusted EBITDA margin increasing to 23.7% from 22.8% year‑over‑year. The improvement stems from higher pricing power in the diversified segments and scale benefits, offsetting modest cost inflation in raw materials.
Management guided 2026 revenue to $550–$580 million and adjusted diluted EPS to $2.30–$2.45, unchanged from prior guidance. The outlook signals confidence in sustained demand for automation, healthcare innovation, and electrification, while acknowledging ongoing softness in transportation.
CEO Kieran O'Sullivan highlighted diversification as a strategic priority, noting that the shift from component supplier to provider of sensors, transducers, and subsystems is delivering higher margins. He also emphasized continued focus on cost discipline and strategic investments in high‑return verticals.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.